Abstract:OBJECTIVE:To investigate the inhibitory effect of silencing androgen receptor (AR) gene by AR short-hairpin RNA (shRNA) on the growth of human prostate cancer xenograft in nude mice.METHODS:Human 22RV1 prostate cancer cells were inoculated subcutaneously into nude mice to establish xenograft models of human prostate cancer. Meanwhile, a short-hairpin RNA that was capable of suppressing the expression of AR was constructed and then recombinant plasmids producing AR shRNA were prepared in a large number. The tumor-bearing mice were randomly divided into 2 groups: the control group and the experimental group. When the tumor volume grew to about 300 mm(3), the plasmids prepared previously were injected into the tail veins of the mice once at the dose of 2 μg/g in the experimental group, whereas the mice in the control group was injected with the same amount of saline as control. The tumor volumes were monitored every other day until 14 days after the treatment.At the endpoint,the mice were sacrificed and the tumors were excised, weighed, fixed in buffered-formalin, and embedded in paraffin for the immunohistochemical analysis of AR,Ki-67 (a marker of proliferative cell) levels and apoptotic cell labeling by TUNEL (terminal deoxynucleotidyl transterase-mediated dUTP nick end labeling) assay. A semiquantitative immunohistochemical scoring system, HSCORE system, was used to evaluate the expression of AR and proliferative index/Ki-67 labeling index (PI/Ki-67 LI) and apoptotic index (AI) were used to assess the cell proliferation and cell apoptosis, respectively.RESULTS:Compared with the control group, the treatment induced an evident inhibitory effect on the tumor growth in the nude mice with prostate cancer. At the endpoint, the tumor volume of (1 199.56±86.48) mm(3) in the experimental group was significantly smaller than that of (1 742.02±98.16) mm3 in the control group (P=0.002). The tumor weight of (1 006.2±79.1) mg in the experimental group significantly decreased compared with that of (1 383.4±74.8) mg in the control group (P=0.005). The AR HSCORE,PI and AI in the experimental group were 25.8±6.7, (26.0±3.1)%, (55.6±7.9)%, respectively, and those in the control group were 268.8± 18.7, (87.6±7.9)%, (27.2±3.9)%, respectively. There were significant differences between the two groups (all P<0.01).CONCLUSION:AR shRNA could be injected intravenously to suppress the expression of AR in vivo and hence inhibit the growth of human prostate cancer xenograft in nude mice.

Inhibitory Effect of Survivin-Sirna on Prostatic Subcutaneous Xenografts in Nude Mice

[Anti-Prostate Cancer Activity of Survivin-T34A Mutant in Vitro and in Vivo].

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity

[Biological Implications of the Inhibition of Survivin by RNA Interference in Human Androgen-Independent Prostate Carcinoma with Highly Metastatic Potential].

[Androgen Receptor Silencing by Shrna Inhibits Human Prostate Cancer Xenograft Growth in Nude Mice].

Effects of survivin siRNA on angiogenesis of papillary thyroid carcinoma xenografts in nude mice

Study of Construction of Sirna Eukaryotic Expression Vector of Survivin Gene and Its Inhibitory Effect on Survivin Expression in Bladder Cancer Cells

The experimental investigation of androgen-independent prostate cancer cell line inhibited growth in vivo by recombinant lentivirus of small interfering RNA (siRNA) targeting NSBP1

[Inhibition of Growth and Angiogenesis of U251 Cell Xenograft in Vivo by Short Hairpin RNA Targeting Survivin Gene].

Antitumor effects of silencing Survivin and Livin gene in prostate cancer cell PC3

[Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models].

Enhancement of Cancer Cell Radiosensitivity by Adenovirus Vector Carrying Sirna of Survivin Gene

Effects of Survivin Small Interfering RNA on Biological Behaviors of Bladder Cancer T24 Cells

Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer

Anti-tumor Effect of RNA Interference Silencing Survivin Gene Combined with X-ray Irradiation on Human Hepatoma Xenograft in Nude Mice

[Inhibitory Effect of Lentiviral Vectors Expressing Small Interfering RNA Targeting Survivin Gene on Hep-2 Cell Growth in Vitro and in Nude Mice].

Shrna Targeting Survivin Gene Suppresses Growth of Bladder Cancer Cell Xenografts in Nude Mice

Tumor-suppressing Effect of Recombinant Adenovirus Encoding LRIG1 Gene Driven by Survivin Promoter in Nude Mice Heterotransplanted Models of Human Bladder Cancer

Effect of Triptolide on PC-3 Cell Xenografts in Nude Mice

Anti-tumor Effect of Silencing HIF-lα and Survivin Genes Combined with Radiotherapy on Human Hepatoma Xenograft in Nude Mice

Survivin siRNA inhibits human laryngeal squamous carcinoma in nude mice